But JB - Your views never seem to consider
1 - Unmet need. 2 - No approved treatments.3 - High Mortility rate.4 - The efficacy that has been demonstrated through a mortality reduction.5 - The opinion of the treating doctor in an open label study.6 - The opinion of the ODAC who considered all of the above.
My question is - why don't you show how you have considered the above, in forming your opinion that you believe there is not enough evidence to approve.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.73 |
Change
0.025(1.47%) |
Mkt cap ! $2.207B | |||
| Open | High | Low | Value | Volume |
| $1.68 | $1.73 | $1.64 | $4.189M | 2.480M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 31201 | $1.72 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.73 | 59276 | 6 |
View Market Depth
| Last trade - 16.10pm 16/07/2025 (20 minute delay) ? |
| MSB (ASX) Chart |